Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.891 AED | -0.11% | -5.21% | +15.86% |
May. 15 | Julphar Resumes Trading on Abu Dhabi Bourse | MT |
May. 15 | Gulf Pharmaceutical Industries Turns to Q1 Profit; Revenue Tumbles | MT |
Sales 2024 * | 1.69B 461M | Sales 2025 * | 1.8B 490M | Capitalization | 1.03B 280M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.07 x |
Net Debt 2024 * | 780M 212M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.57 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 2,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 30.76% |
1 day | -0.11% | ||
1 week | -5.21% | ||
Current month | -5.31% | ||
1 month | -5.41% | ||
3 months | -14.33% | ||
6 months | +17.24% | ||
Current year | +15.86% |
Managers | Title | Age | Since |
---|---|---|---|
Basel Ziyadeh
CEO | Chief Executive Officer | - | - |
Ignacio Anglada
DFI | Director of Finance/CFO | - | - |
Malik Metahri
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rabih Khouri
BRD | Director/Board Member | - | 21-07-31 |
Director/Board Member | - | 16-12-31 | |
Jean Diab
BRD | Director/Board Member | - | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 0.891 | -0.11% | 147,310 |
24-05-24 | 0.892 | -1.55% | 852,734 |
24-05-23 | 0.906 | -2.37% | 360,601 |
24-05-22 | 0.928 | -0.43% | 121,767 |
24-05-21 | 0.932 | -0.85% | 119,886 |
Delayed Quote Abu Dhabi Securities Exchange, May 27, 2024 at 06:33 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.86% | 280M | |
+16.17% | 79.03B | |
+8.65% | 8.78B | |
-16.43% | 4.83B | |
+48.34% | 4.65B | |
+2.91% | 3.89B | |
+14.51% | 2.34B | |
-26.94% | 2.18B | |
+16.55% | 2.11B | |
-36.25% | 2B |
- Stock Market
- Equities
- JULPHAR Stock